Neuroscience Letters 2002-11-15

Chrysamine G and its derivative reduce amyloid beta-induced neurotoxicity in mice.

Kazuhiro Ishii, William E Klunk, Shigeki Arawaka, Manik L Debnath, Yoshiko Furiya, Naruhiko Sahara, Shin'ichi Shoji, Akira Tamaoka, Jay W Pettegrew, Hiroshi Mori

文献索引:Neurosci. Lett. 333 , 5-8, (2002)

全文:HTML全文

摘要

The neurotoxicity of amyloid beta (Abeta) is widely believed to play a seminal role in neurodegeneration in Alzheimer's disease. We examined the effect of Chrysamine G (CG) on such neurotoxicity using the specific measurement of surviving neurons. CG was found to reduce the neurodegeneration induced by both the active short fragment of Abeta(25-35) and full-sized Abeta(1-40). In this study, we synthesized a new chemical compound from a monovalent structure of CG (hCG), with a lower affinity for Abeta, and compared its activity with that of CG. Both CG and hCG were found to be equally efficacious in reducing Abeta-induced neuronal death at a concentration of 0.1-1 microM, indicating that the mechanism of action for CG was not due to its chelating activity, but rather due to its anti-oxidant activity.Copyright 2002 Elsevier Science Ireland Ltd.


相关化合物

  • N-芴甲氧羰基-D-1,...

相关文献:

Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative.

2002-09-01

[J. Neuropathol. Exp. Neurol. 61 , 797-805, (2002)]

Amyloid binding ligands as Alzheimer's disease therapies.

2002-01-01

[Neurobiol. Aging 23 , 1039-1042, (2002)]

99mTc-MAMA-chrysamine G, a probe for beta-amyloid protein of Alzheimer's disease.

1999-11-01

[Eur. J. Nucl. Med. 26(11) , 1392-9, (1999)]

Inhibition of polyglutamine aggregation in R6/2 HD brain slices-complex dose-response profiles.

2001-12-01

[Neurobiol. Dis. 8(6) , 1017-26, (2001)]

In vitro drug treatments reduce the deleterious effects of aggregates containing polyAla expanded PHOX2B proteins

2012-01-01

[Neurobiol. Dis. 45 , 508-18, (2012)]

更多文献...